Publications by authors named "Yan Zhi Wu"
Purpose: To explore the predictive value of nutritional risk for all-cause death and functional outcomes among elderly acute stroke patients.
Patients And Methods: A total of 479 elderly acute stroke patients were enrolled in this study. The nutritional risk of patients was screened by the GNRI and NRS-2002.
Background: Stroke is a leading cause of death and functional impairment in older people. To assess the prospective association between fasting blood glucose-to-glycated hemoglobin ratio and all-cause mortality and poor prognosis in stroke patients.
Methods: A total of 971 Chinese inpatients with acute stroke (mean age of 65.
Nutritional Risk Screening index is a standard tool to assess nutritional risk, but epidemiological data are scarce on controlling nutritional status (CONUT) as a prognostic marker in acute haemorrhagic stroke (AHS). We aimed to explore whether the CONUT may predict a 3-month functional outcome in AHS. In total, 349 Chinese patients with incident AHS were consecutively recruited, and their malnutrition risks were determined using a high CONUT score of ≥ 2.
View Article and Find Full Text PDFBackground: Malnutrition is confirmed to be associated with poor outcomes in stroke patients. The present study aimed to confirm that being at risk of malnutrition assessed by Nutritional Risk Screening Tool 2002 (NRS-2002) and the Controlling Nutritional Status (CONUT) score predicts poor outcomes at 3 months in acute ischemic stroke (AIS) patients.
Methods: In total, 682 patients with AIS were recruited within 7 days of stroke onset consecutively and 110 were dropped out.
Article Synopsis
- A study investigated the effectiveness of Human Urinary Kallikrein for treating acute cerebral infarction by comparing two groups of 110 patients, one receiving the treatment and the other acting as a control.
- Both groups showed improvements in stroke severity scores after treatment, but the kallikrein treatment group had significantly better results than the control group, especially for patients with large-artery and small-artery subtypes.
- The effective treatment rate was 81.82% in the kallikrein group compared to 54.55% in the control group, highlighting the potential benefits of Kallikrein for acute stroke patients.